08:30	Registration
09:00	Welcome Address, Martijn Kleijwegt, LSP
09:15	Aad de Winter, NYSE Euronext
09:30	Keynote Address, Stefan Aigner, Alpharma
10:00	Coffee/Tea Break; sponsored by Lovells
	Company Presentations
	Session Room 1	Session Room 2	Session Room 3
10:20	Galapagos (BE) - Public	Avantium Technologies (NL)	ActoGeniX (BE)
10:40	Kiadis Pharma (NL)	Fovea Pharmaceuticals (FR)	Vivendy Therapeutics (CH)
11:00	OctoPlus (NL) - Public	Affectis (GER)	ProteoNic (NL)
11:20	Cellerix (ES)	Agendia (NL)	EyeSense (GER)
11:40	ThromboGenics (BE) - Public	Pronota (BE)	Kreatech (NL)
12:00	Lunch; sponsored by KPMG
13:30	Edwin Liem, Baker & McKenzie
13:45	Keynote Address, Dr Andrew Wood, Lilly UK: A current perspective on partnerships at Eli Lilly & Co
	Company Presentations
	Session Room 1	Session Room 2	Session Room 3
14:15	Hybrigenics (FR) - Public	Santaris Pharma (DK)	ProFibrix (NL)
14:35	Movetis (BE)	4-Antibody (CH)	KeyNeurotek (GER)
14:55	Ablynx (BE) - Public	Prosensa (NL)	AM-Pharma (NL)
15:15	Jerini (GER) - Public	Zealand Pharma (DK)	Elbion (BE)
15:35	Coffee/Tea Break; sponsored by Ernst & Young
	Company Presentations
	Session Room 1	Session Room 2	Session Room 3
15:55	Pharming (NL) - Public	Pepscan Therapeutics (NL)	Skyline Diagnostics (NL)
16:15	Innate Pharma (FR) - Public	Syntaxin (UK)	Nexstim (FIN)
16:35	OncoMethylome Sciences (BE) - Public	PanGenetics (NL)	BMEYE (NL)
16:55	BioAlliance Pharma (FR) - Public	Affimed (GER)	f-star (AUT)
17:15	4SC (GER) - Public	GlycoVaxyn (CH)	reMYND (BE)
17:35	Drinks reception; sponsored by Amsterdam BioMed Cluster
18:30	Close of the conference